NHS staff striking over pay
October 13, 2014Medical Communications, Sales and Marketing British Association of Occupational Therapists., GMB, GPs, Hunt, NHS, UCATT, midwives, strike
Over 400,000 NHS staff have gone on strike for four hours as a 1% pay rise requested by Unions was …
Patricell appoints sales executive
October 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing carla stemate, patricell
Nottingham-based healthcare products firm Patricell is adding Carla Stemate to its team as a sales executive. Based at BioCity, Stemate …
Pharma and transparency: actions speak louder than words
October 13, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, alltrials, andrew powrie-smith, hcp, transparency
As an industry we continue to deliver innovative, life changing medicines and rewrite the story of many diseases, yet our …
Novartis signs $90m deal with Oxford BioMedica
October 10, 2014Manufacturing and Production, Research and Development, Sales and Marketing CART-019, Novartis, Oxford BioMedica, immunotherapy, oxb
UK-based biotech Oxford BioMedica is working with Novartis in a transformational deal for the firm worth $90 million to develop …
Endo buys Auxilium for $2.6 billion
October 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Endo, Testim, Testopel, auxilum
Endo International has agreed a $2.6 billion deal to buy Auxilium Pharmaceuticals in order for the company to gain access …
New chief executive for Tonic Life Communications
October 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huntsworth Health, mary smiddy, tonic life communications
Healthcare comms consultancy Tonic Life Communications that is a part of the Huntsworth Health family of agencies, has confirmed the …
AstraZeneca president to lead Sanofi UK
October 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Sanofi, Tarja Stenvall
Sanofi has appointed Tarja Stenvall to be its new general manager for the UK and Ireland. Stenvall joins Sanofi from …
Charity launches second cancer research game
October 9, 2014Medical Communications, Sales and Marketing CRUK, Cancer, amazon, genes in space, oncology, play, reverse the odds
Cancer Research UK has launched its second citizen science game this year called ‘Reverse The Odds’ in an attempt to …
Supervisory board member joins Bayer
October 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Otmar Wiestler
Professor Otmar Wiestler has been appointed to the supervisory board at German pharma giant Bayer. He replaces Dr Klaus Kleinfeld …
Texas Ebola victim dies as diseases spreads
October 9, 2014Medical Communications, Sales and Marketing Chicago O’Hare, Ebola, Hartsfield-Jackson Atlanta, Newark Liberty, Thomas Eric Duncan, UK, US, Washington Dulles
A Liberian national named Thomas Eric Duncan has died in an isolation ward of a Dallas, Texas hospital after being …
Novartis says three executives departing firm
October 9, 2014Medical Communications, Sales and Marketing Andrin Oswald, Brian McNamara, GSK, George Gunn, Novartis, lilly, oncology, vaccines
Swiss pharma giant Novartis has announced three of its executives are to leave the firm following deals with Lilly and …
RSA makes three appointments
October 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mateja Forstnaric, Nicholas Draeger, Stefanie Blasi, rsa
Life sciences executive search and interim management firm RSA has appointed three consultants to its European teams.
 Stefanie Blasi (pictured) …
European Medicines Group appoints two officers
October 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Garmon-Jones, EMG, Zinta Krumins
The European Medicines Group has elected new chairs to the body in David Garmon-Jones and Zinta Krumins, who will be …
Mayor of London calls for dementia R&D centre
October 8, 2014Research and Development, Sales and Marketing Alzheimer's, Boris Johnson, London, dementia, research
The mayor of London Boris Johnson is calling on both the government and the private sector to come together and …
Pharma ‘cannot deliver patient centricity’
October 8, 2014Research and Development, Sales and Marketing European Brain Council, barcelona, eyeforpharma, mary baker
The former president of the European Brain Council Mary Baker believes pharma companies are focussing too much on patient centricity, …
Verona Pharma appoints chief financial officer
October 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing roy biresh, verona pharma
London-based drug development firm Verona Pharma has hired Biresh Roy as its chief financial officer and member of the board …
Public opinion divided over UK drugs spend
October 7, 2014Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, NHS, NICE, PPRS, UK, coalition, drugs spending, government
A new survey conducted for the ABPI shows that public opinion on whether the UK spends enough money on medicines …
BMS pulls hep C combo treatment in US
October 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Combo, HCV, asunaprevir, daclatasvir, hep C, sovaldi
Bristol-Myers Squibb will not attempt to bring its new combination hepatitis C treatment to the US market given the current …
Triducive appoints senior account manager
October 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Triducive, ian walker, walker, warren
UK healthcare comms consultancy firm Triducive has appointed a new senior account manager in Ian Walker. Walker is a project …
Sovaldi ‘unaffordable’ says NHS documents
October 7, 2014Medical Communications, Research and Development, Sales and Marketing NHS England, fund, hep C, sovaldi
Senior health officials may have to bar Gilead’s new hepatitis C pill Sovaldi from being funded on the NHS after …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
